title: Comments on 'Anti-IgE therapy for eosinophilic disorders'.
authors: Department of Otolaryngology, GATA Haydarpasa Training Hospital, Istanbul, Turkey drmuratsali@gmail.com Department of Dermatology, GATA Haydarpasa Training Hospital, Istanbul, Turkey Department of Allergy and Immunology, GATA Haydarpasa Training Hospital, Istanbul, Turkey Department of Pathology, GATA Haydarpasa Training Hospital, Istanbul, Turkey.
authors: Murat
authors: M
authors: Salihoglu
authors: Ercan
authors: E
authors: Karabacak
authors: Ali
authors: A
authors: Kutlu
authors: Aptullah
authors: A
authors: Haholu
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D004804:Eosinophils; D005260:Female; D006801:Humans; D007073:Immunoglobulin E; D008297:Male; D010034:Otitis Media with Effusion / Q000188:drug therapy*
chemical_list: D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D007073:Immunoglobulin E